This site is intended for healthcare professionals only
DiabetesontheNet Logo
×

This promotional webinar has been developed, organised and funded by Boehringer lngelheim. Boehringer lngelheim products will be discussed during this event. The content has been reviewed and approved by sponsoring company and the speakers prior to the webinar. The speakers have received an honorarium to take part in this promotional webinar. Editorial support for this website has been provided by OmniaMed Communications.

Click here to view  Great Britain, Northern Ireland & Ireland prescribing information

About the programme

In 2022, Ramadan will take place on or around Saturday 2 April to Sunday 1 May.1 For adults living with type 2 diabetes, providing Ramadan-focused education at least 6–8 weeks before Ramadan is recognised as the cornerstone to safer fasting.2

Join us for a live webinar on Wednesday 16 February at 12:30 and 19:00 hosted by Dr Sarah Jarvis, General Practitioner, London and Clinical Director at Patient.info and Professor Wasim Hanif, Professor of Diabetes & Endocrinology, Consultant Physician and Head of Service in Diabetes, Birmingham. Together they will discuss how to assess the potential risks associated with fasting, conduct pre-Ramadan medication reviews, and offer practical advice to adults with type 2 diabetes who wish to fast.

References
1. Diabetes UK (2021) Ramadan and diabetes. Available at: https://www.diabetes.org.uk/guide-to-diabetes/managing-your-diabetes/ramadan (accessed December 2021)
2. International Diabetes Federation and the Diabetes and Ramadan International Alliance (2021) Diabetes and Ramadan practical guidelines 2021. Available at: https://www.daralliance.org/daralliance/idf-dar-practical-guidelines-2021/ (accessed December 2021)

Agenda

Start the conversation early: Actively support your patients with type 2 diabetes during Ramadan
Wednesday 16 February 2022 at 12:30 and 19:00

10 min

Welcome and introduction

Sarah Jarvis
20 min

Risk, assessment, screening and advice: The cornerstone to navigating type 2 diabetes and Ramadan

Wasim Hanif
15 min

Live Q&A

Sarah Jarvis and Wasim Hanif

Speakers

Dr Sarah Jarvis MBE, FRCGP
Dr Sarah Jarvis
GP, Medical Broadcaster and Clinical Director, Patient.info

Sarah Jarvis trained at Cambridge and Oxford universities and has been a partner in the same inner city general practice for 26 years. She is an active medical writer and broadcaster and is the BBC Radio 2 doctor and the doctor to The One Show on BBC 1. Besides these roles, she has been a regular contributor to a variety of medical journals including Update, Doctor, Practice Nurse and the British Journal of Cardiology. Dr Jarvis is past chair of the Healthcare Committee of HEART UK, the cholesterol charity and is a member of the advisory board for the British Journal of Cardiology. Dr Jarvis has a particular interest in cardiovascular disease, diabetes and women’s health.

In 2021, Dr Jarvis was appointed Visiting Professor of General Practice at the University of Huddersfield.

Professor Wasim Hanif
Professor Wasim Hanif
Professor of Diabetes & Endocrinology, Consultant Physician and Head of Service in Diabetes, Birmingham

Wasim Hanif is a Professor of Diabetes & Endocrinology, Consultant Physician, and Head of Service in diabetes at University Hospital Birmingham. He is an Honorary Professor of Medicine at the University of Warwick. He is a Board Member for the Centre for Diabetes, Endocrinology and Metabolism, University of Birmingham, and Clinical Advisory Group Lead for research in Diabetes and Endocrinology at the Institute of Translational Medicine, Birmingham. He is a visiting Professor at Birmingham City University and Medical Director of the Advanced Diabetes Course.
He is an eminent authority on diabetes, obesity, and ethnic health, working with several national bodies and professional groups in the UK. He has been involved with major research projects in diabetes and has published widely. His research interest includes diabetic kidney disease, diabetes prevention, cardiovascular disease in diabetes, diabetes in Ramadan, obesity, ethnicity and tackling health inequalities. He is a well known authority on real world evidence, working on big data with a dedicated bioinformatics team.
He is involved as a chief and principal investigator in several international multicentre trials and was instrumental in setting up UKADS (United Kingdom Asian Diabetes Study). Professor Hanif has been involved at a parliamentary level advising the government on issues related to diabetes and ethnic health. He is the Chair of the Diabetes Working Group of the world-recognised South Asian Health Foundation (SAHF). Professor Hanif is a member of the Parliamentary and Stakeholder Diabetes Think Tank advising the All-Party Parliamentary Group on Diabetes. He is a member European Policy Forum on diabetes advising the European Union. His involvement in NICE has been extensive, sitting on advisory NICE Health Technology Appraisal Committee between 2009 and 2015. He is on the Expert Advisory Committee for the Commission of Human Medicine, advising the MHRA on new medicinal agents. He is on the Board of Governors as a Trustee of Diabetes UK and is involved in several international projects including the IDF WHO Global Policy Forum on Diabetes. He is a recipient of several national and international awards including the prestigious SAHF UK Lifetime Achievement Award.

Start the conversation early: Actively support your patients with type 2 diabetes during Ramadan

Wednesday 16 February 2022 at 12:30 and 19:00

This promotional webinar has been developed, organised and funded by Boehringer lngelheim. Boehringer lngelheim products will be discussed during this event. The content has been reviewed and approved by sponsoring company and the speakers prior to the webinar. The speakers have received an honorarium to take part in this promotional webinar. Editorial support for this website has been provided by OmniaMed Communications.

Click here to view  Great Britain, Northern Ireland & Ireland prescribing information

Adverse events should be reported. Reporting forms and information can be found at https://www.mhra.gov.uk/yellowcard (UK) or https://www.hpra.ie/homepage/about-us/report-an-issue (IRE). Adverse events should also be reported to Boehringer lngelheim Drug Safety on 0800 3281627 (freephone) (UK) or 01 2913960, Fax: +44 1344 742661, or by e-mail: PV_local UKlreland@boehringer-ingelheim.com (IRE).

For the latest news and articles

Sign up to all DiabetesontheNet journals

© Copyright Omniamed Communications. All Rights Reserved​
108 Cannon Street, London, EC4N 6EU. Registered in the United Kingdom​
Omniamed logo white
DiabetesontheNet Logo
For the latest news and articles

Sign up to all DiabetesontheNet journals

 

By clicking ‘Subscribe’, you are agreeing that DiabetesontheNet.com are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.

DiabetesontheNet Logo

This website is for UK healthcare professionals only. To continue, please confirm that you are a UK healthcare professional below.